Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study.

<h4>Background</h4>Vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is available in the United Kingdom to adults aged 65 years or older and those in defined clinical risk groups. We evaluated the vaccine effectiveness (VE) of PPV23 against vaccine-type pneumococ...

Full description

Bibliographic Details
Main Authors: Hannah Lawrence, Harry Pick, Vadsala Baskaran, Priya Daniel, Chamira Rodrigo, Deborah Ashton, Rochelle C Edwards-Pritchard, Carmen Sheppard, Seyi D Eletu, David Litt, Norman K Fry, Samuel Rose, Caroline Trotter, Tricia M McKeever, Wei Shen Lim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-10-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003326

Internet

https://doi.org/10.1371/journal.pmed.1003326

Similar Items